ReviewEndocrine journal2026
Low-affinity IgG-mediated macro-TSH: diagnostic limitations of peak-based gel filtration chromatography-a case report with review of literature.
Review in Endocrine journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Macrohormones in endocrinology: prevalence, clinical impact, and diagnostic approaches.Frontiers in endocrinology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Macro-thyroid-stimulating hormone (macro-TSH) is a well-recognized cause of spuriously elevated TSH results. However, its characterization still relies largely on gel filtration chromatography (GFC), which may fail to detect macro-TSH associated with unstable or low-affinity immune complexes. In particular, when second-line screening tests, such as polyethylene glycol (PEG) precipitation, strongly suggest macro-TSH but GFC shows no distinct high-molecular-weight TSH fraction, macro-TSH may be incorrectly ruled out as the source of interference. A 43-year-old woman treated with levothyroxine for subclinical hypothyroidism showed persistently elevated TSH despite high-normal free thyroxine levels and no clinical signs of hypothyroidism. PEG precipitation and Protein G treatment resulted in TSH recovery rates of 8% and 23%, respectively, indicating macro-TSH mediated by immunoglobulin G, while heterophile and assay-specific interferences were considered unlikely. GFC under neutral conditions revealed a subtly broadened TSH distribution without a distinct high-molecular-weight peak. Quantitative peak analysis showed increased full width at half maximum and area under the curve, with values approximately 1.5- to 2-fold higher than those in controls in both the initial and repeat runs, confirming significant peak broadening. Under acidic conditions, the patient's TSH elution profile completely overlapped with those of the controls, supporting the presence of macro-TSH due to low-affinity TSH-IgG complexes. This case highlights the diagnostic challenge posed by macro-TSH, particularly in cases involving low-affinity antibody interactions. It underscores the importance of assessing the overall elution profile rather than relying solely on peak position. Recognizing such atypical presentations can prevent unnecessary thyroid hormone treatment and improve diagnostic accuracy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.